Abstract

ABSTRACT Background: The present study was conducted to validate the Persian version of the AWAER questionnaire (Preventive Warning of Relapse – Revised Form) in methamphetamine users. Method: The statistical population consisted of all the methamphetamine users referring to the addiction treatment centers of Kermanshah, Iran, and 388 people were selected by two-step random cluster sampling. Result: The Cronbach’s alpha coefficient for the AWARE questionnaire was 0.95, indicating the desired validity of the Persian form. Exploratory factor analysis with varimax rotation indicated three factors, namely depression, anxiety, and relapse, with a total variance explanation of 63.3%. Also, the correlation coefficient obtained between the extracted factors with each other and the entire items indicated a desirable structural validity. Given the elimination of three items, the Persian version of the questionnaire was finally obtained with 25 items and three factors. Test–retest reliability was 0.79 with a one-week interval. The correlation coefficient between the AWARE questionnaire and AWQ-V2 scores was obtained as 0.526 for determining the convergent validity (P < .01). Conclusion: The Persian version of the AWARE questionnaire in methamphetamine users’ community has a favorable validity and reliability and can therefore be used to assess the symptoms of advance warning of relapse in Persian-speaking methamphetamine users, such as those in Iran.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.